Human Oncology & Pathogenesis Program
The Jorge Reis-Filho Lab
Research
My laboratory focuses on the discovery of the underlying genetic traits and dependencies of breast cancers based on a combination of traditional pathologic approaches with genomics, functional genomics and artificial intelligence to devise a taxonomy system for these tumors that more accurately reflects their biology and therapeutic vulnerabilities.
Featured News
Publications
People
Jorge S. Reis-Filho, MD, PhD
- Physician-scientist Jorge Reis-Filho focuses on the development of a predictive molecular classification for rare types of breast cancer and characterization of intratumor genetic heterogeneity in breast cancers.
- MD, University of Porto (Portugal) and Federal University of Parana (Curitiba, Brazil)
- PhD, University of Minho (Braga, Portugal) and The Institute of Cancer Research (London, UK)
- reisfilj@mskcc.org
- Email Address
- View physician profile
- Physician profile
Members
Lab Alumni
Lab Affiliations
Achievements
- Future Leaders in Cancer Research Prize, Cancer Research UK (2010)
- Ramzi Cotran Young Investigator Award, United States and Canadian Academy of Pathology (2010)
- Young Cancer Researcher Award -- Highly Commended, European Association for Cancer Research (2008)
- CL Oakley Lectureship, Pathological Society of Great Britain and Ireland (2007)
- Translational Research Award, British Association for Cancer Research (2007)
Read more
- Sir Anthony Driver Award, Breakthrough Breast Cancer, Institute of Cancer Research (2005)
Open Positions
To learn more about available postdoctoral opportunities, please visit our Career Center
Postdoctoral Research Fellow
We are currently seeking a postdoctoral research fellow to join our team of bioinformaticians, molecular biologists, and fellows in the development of methods for the analysis of novel approaches for single cell sequencing and cfDNA analysis.
Get in Touch
-
Lab Head Email
Disclosures
Doctors and faculty members often work with pharmaceutical, device, biotechnology, and life sciences companies, and other organizations outside of MSK, to find safe and effective cancer treatments, to improve patient care, and to educate the health care community.
MSK requires doctors and faculty members to report (“disclose”) the relationships and financial interests they have with external entities. As a commitment to transparency with our community, we make that information available to the public.
Jorge S. Reis-Filho discloses the following relationships and financial interests:
-
Belgian Volition
Provision of Services -
Eli Lilly and Company
Provision of Services (uncompensated) -
Goldman Sachs
Provision of Services -
Oncoclinicas do Brasil Servicos Medicos S.A.
Fiduciary Role/Position; Ownership / Equity Interests
-
Paige.AI, Inc.
Ownership / Equity Interests; Provision of Services -
Repare Therapeutics
Ownership / Equity Interests; Provision of Services -
prIME Oncology
Provision of Services
The information published here is for a specific annual disclosure period. There may be differences between information on this and other public sites as a result of different reporting periods and/or the various ways relationships and financial interests are categorized by organizations that publish such data.
This page and data include information for a specific MSK annual disclosure period (January 1, 2020 through disclosure submission in spring 2021). This data reflects interests that may or may not still exist. This data is updated annually.
Learn more about MSK’s COI policies here. For questions regarding MSK’s COI-related policies and procedures, email MSK’s Compliance Office at ecoi@mskcc.org.